HAVAR vs SYK
Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to Class A ordinary Shares (HAVAR) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Harvard Ave Acquisition Corporation Rights that convert on a 1/10th of 1 basis to Class A ordinary Shares (HAVAR) common stock listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
HAVAR does not have a complete income-statement cache yet.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
HAVAR currently screens at market cap $0. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the HAVAR and SYK stock pages for the full models.
Not investment advice.